Serum amyloid A and Interleukin-1 (IL-1) receptor antagonist (A-SAA and IL-1Ra) values; * Comparison of pregnant women with and without GDM diagnosis * Comparison of insulin therapy and diet-regulated GDM patients * Comparison of pregnant women with and without LGA (large gestational age) * Comparison of pregnant women with and without polyhydroamnios * Investigation of its effect on pregnancy prognosis * In the prediction of GDM diagnosis, it is aimed to study the sensitivity and specificity of both parameters and cut off values. (In GDM patients, liver and kidney function parameters will also be evaluated with A-SAA and IL-1Ra levels).
Study Type
OBSERVATIONAL
Enrollment
80
Women who are diagnosed with GDM between the ages of 18 and 43 will receive blood in the biochemistry tube. This tube will then be centrifuged. A-SAA and IL-1Ra levels will be checked by ELISA method in serum stored at -80 degrees.
Women who are diagnosed with GDM between the ages of 18 and 43 will receive blood in the biochemistry tube. This tube will then be centrifuged. A-SAA and IL-1Ra levels will be checked by ELISA method in serum stored at -80 degrees.
Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, Turkey (Türkiye)
Serum amyloid A
Its level will be checked in the study group consisting of pregnant women with GDM and in the control group consisting of healthy pregnant women.
Time frame: 1 week
Interleukin-1 (IL-1) receptor antagonist
Its level will be checked in the study group consisting of pregnant women with GDM and in the control group consisting of healthy pregnant women.
Time frame: 1 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.